Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial

BACKGROUND: Progressive pancreatic β cell dysfunction is a fundamental aspect of the pathology underlying type 2 diabetes mellitus (T2DM). Recently, mesenchymal stem cell (MSC) transplantation has emerged as a new therapeutic method due to its ability to promote the regeneration of pancreatic β cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Xiao-Fen, Lu, Dong-Hui, Liu, Hong-Li, Liu, Yan-Jing, Yang, Yang, Lin, Yuan, Xie, Feng, Huang, Cai-Hao, Wu, Hong-Mei, Long, Ai-Mei, Hui, Chen-Jun, Shi, Yu, Chen, Yun, Gao, Yun-Feng, Zhang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424020/
https://www.ncbi.nlm.nih.gov/pubmed/37583846
http://dx.doi.org/10.12998/wjcc.v11.i21.5083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424020/
https://www.ncbi.nlm.nih.gov/pubmed/37583846
http://dx.doi.org/10.12998/wjcc.v11.i21.5083

Ejemplares similares